PUBLIC COMPANY
saveObsidian Therapeutics Inc
updated 4mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- A booming business on Wall Street would love more biotechs to quietly dieOnce disparaged, reverse mergers have become so popular that some deal experts question whether there are enough quality shell companies to meet the demand.biopharma_dive · 23d ago
- Biopharma reverse mergers rise 1,600% in Q3 to rival IPOsAlmost as many biotechs have opted for a reverse merger to reach the public markets as those executing more traditional initial public offerings this year.biospace · 1mo ago
comments(0)
5-min edit window · permanent after that